Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma
Clinical trial NCT03056001 · COMPLETED
Trial details
- NCT number
- NCT03056001
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2021-11-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.